Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
As of today, Halozyme Therapeutics(HALO) shares are valued at $64.49. The company's market cap stands at 7.64B, with a P/E ratio of 25.56.
On 2026-04-28, Halozyme Therapeutics(HALO) stock opened at $65.40, reached a high of —, and a low of —.
Halozyme Therapeutics(HALO) shares are trading with a volume of 0, against a daily average of 1.46M.
In the last year, Halozyme Therapeutics(HALO) shares hit a 52-week high of $82.22 and a 52-week low of $47.50.
In the last year, Halozyme Therapeutics(HALO) shares hit a 52-week high of $82.22 and a 52-week low of $47.50.
Analyst ratings
60%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.